| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/30/2003 | US6627799 Genetic engineered cells having ability to adjust to environment and have plant disease resistance; hybrids |
| 09/30/2003 | US6627798 Nucleotide sequences coding polypeptide associated with tyrosine biosynthesis for use in generation of amplified tyrosine concentration in plants |
| 09/30/2003 | US6627797 Maize lipoxygenase polynucleotide and methods of use |
| 09/30/2003 | US6627796 Increasing the Rar1 concentration in the composition of plant to increase their resistance to plant diseases; recombinant expression cassettes; host cells; transgenic plants; crops |
| 09/30/2003 | US6627795 DNA and/or complements comprising nucleotide sequences that code for polypeptides having lyase enzyme activity; genetic engineering |
| 09/30/2003 | US6627793 Low temperature-inducible wheat WCS120 gene promoter |
| 09/30/2003 | US6627747 Essential bacterial genes and their use |
| 09/30/2003 | US6627746 DNA comprising nucleotide sequences that code for somatomedins and peptide domains |
| 09/30/2003 | US6627745 Pyrin gene and mutants thereof, which cause familial Mediterranean fever |
| 09/30/2003 | US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it |
| 09/30/2003 | US6627740 Monoclonol antibody which binds to a polypeptide having pre-B cell growth supporting ability |
| 09/30/2003 | US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease |
| 09/30/2003 | US6627736 Pap mutants that exhibit anti-viral and/or anti-fungal activity in plants |
| 09/30/2003 | US6627735 Islet cell antigen 1851 |
| 09/30/2003 | US6627734 Given amino acid sequence, expression vectors; regulation of the KOR-3 splice variant activities may impact analgesia and weight management |
| 09/30/2003 | US6627730 Of given amino acid sequence, and diagnostic test kit; multidrug resistance |
| 09/30/2003 | US6627728 BASB010 polypeptides; fusion proteins; use in vaccines against bacterial infections including otitis media; related by sequence homology to TlyC hemolysin protein of Serpulina hyodysenteriae |
| 09/30/2003 | US6627619 Cancer diagnosis |
| 09/30/2003 | US6627618 Non-viral vector which can bind to desired DNA to form a combination useful to transfect diseased mitochondria of human or animal cells; vector comprises a dequalinium salt subjected to standard liposome production procedures |
| 09/30/2003 | US6627617 Temperature-sensitive regulation of viral vector production |
| 09/30/2003 | US6627616 Intravascular delivery of non-viral nucleic acid |
| 09/30/2003 | US6627615 Methods and compositions for in vivo gene therapy |
| 09/30/2003 | US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with |
| 09/30/2003 | US6627601 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier |
| 09/30/2003 | US6627456 Method for selecting functional deoxyribonucleotide derivatives |
| 09/30/2003 | US6627449 Fluorescent protein sensors for measuring the pH of a biological sample |
| 09/30/2003 | US6627442 Methods for stable transduction of cells with hiv-derived viral vectors |
| 09/30/2003 | US6627438 Nucleotide sequences for use in the generation of amidated peptides |
| 09/30/2003 | US6627437 GBV sequence |
| 09/30/2003 | US6627436 Vector for gene expression in prokaryotic and eukaryotic systems |
| 09/30/2003 | US6627429 Using a methyl esterase; deesterification; allows proteins to be stable in acidic solutions; useful in preparation of foodstuff |
| 09/30/2003 | US6627427 Recombinant Saccharopolyspora erythraea cell; expression vector for given gene from Streptomyces collinus or Streptomyces coelicolor; biosynthesis; useful for producing polyketides |
| 09/30/2003 | US6627424 Protein comprising a sequence non-specific binding domain and a DNA polymerase domain; enhances binding and catalytic activity |
| 09/30/2003 | US6627421 Ultrasonic and electrical; sonoelectroporation tranducer; use for formation of pores; enhances gene expression, transfection, transformation and uptake of materials by the cell; automatic; probes |
| 09/30/2003 | US6627420 Process for the production of alanine by recombinant microorganisms |
| 09/30/2003 | US6627418 Isolated nucleic acid of given DNA sequence; polymerase chain reaction; use in determining correlation betweeen activation/infection towards disease during renal transplantation; cytomegalovirus |
| 09/30/2003 | US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation |
| 09/30/2003 | US6627414 Genetic engineering; overlapping Dna sequences |
| 09/30/2003 | US6627405 53BP2 complexes |
| 09/30/2003 | US6627400 Contacting a binding compound having reporters molecules with a sample; cleaving; electrophoretically separating and identifying the released reporter molecules |
| 09/30/2003 | US6627399 Using compound of given formula as accelerator |
| 09/30/2003 | US6627398 System for reproducing and modulating stability and turnover of RNA molecules |
| 09/30/2003 | US6627226 Dry solid medium for storage and analysis of genetic material |
| 09/30/2003 | US6627218 Cationic lipid with a lipophilic group derived from cholesterol; an amide or carbamate linker bond; an alkylene spacer arm; and a cationic primary, secondary, tertiary or quaternary amino group. facilitating nucleic acid transfer |
| 09/30/2003 | US6627215 Devices for improved wound management |
| 09/30/2003 | US6627204 Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 09/30/2003 | US6627203 Non-virulent culture of Arthrobacter |
| 09/30/2003 | US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes |
| 09/30/2003 | US6627190 Telomerase resistance; anticancer agents |
| 09/30/2003 | US6627189 Supressing expression of human p21 K-ras oncogene |
| 09/30/2003 | US6627186 Treating neutrophil disorders; granulocyte colony stimulating factor (G-CSF) |
| 09/30/2003 | CA2262465C Neuritin, a neurogene |
| 09/30/2003 | CA2168382C Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine |
| 09/30/2003 | CA2141439C Method for highly purifying human serum albumin |
| 09/30/2003 | CA2140921C Method and kit for pyridinium crosslink assay |
| 09/30/2003 | CA2133759C Evaluation and treatment of patients with progressive immunosuppression |
| 09/30/2003 | CA1341440C Cdna coding for carcinoembryonic antigen |
| 09/29/2003 | CA2422319A1 Cancer diagnostic panel |
| 09/29/2003 | CA2422305A1 Assessing colorectal cancer |
| 09/29/2003 | CA2422303A1 Breast cancer prognostic portfolio |
| 09/29/2003 | CA2422298A1 Colorectal cancer diagnostics |
| 09/28/2003 | CA2379661A1 Paracellular drug delivery system |
| 09/25/2003 | WO2003079667A1 Improved nucleic acid amplification |
| 09/25/2003 | WO2003079286A1 Medical applications of adaptive learning systems using gene expression data |
| 09/25/2003 | WO2003079029A1 Positioning system for moving a selected station of a holding plate to a predetermined location for interaction with a probe |
| 09/25/2003 | WO2003079025A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 09/25/2003 | WO2003079024A1 Filament-recruiting fluorescent proteins for the analysis and identification of protein-protein-interactions |
| 09/25/2003 | WO2003079020A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer |
| 09/25/2003 | WO2003078991A1 Vertical impedance sensor arrangement and method for producing a vertical impedance sensor arrangement |
| 09/25/2003 | WO2003078662A1 Gene expression profiling in biopsied tumor tissues |
| 09/25/2003 | WO2003078659A2 Microcapsules with controlable permeability encapsulating a nucleic acid amplification reaction mixture and their use as reaction compartments for parallels reactions |
| 09/25/2003 | WO2003078658A2 Methods for diagnosing and treating schizophrenia |
| 09/25/2003 | WO2003078651A2 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits |
| 09/25/2003 | WO2003078650A2 Manganese ion regulation of reverse transcriptase activity and methods of modulating same |
| 09/25/2003 | WO2003078645A2 Methods for generating double stranded dna comprising a 3’ single stranded portion and uses of these complexes for recombination |
| 09/25/2003 | WO2003078642A1 Saccharomyces cerevisiae mutant |
| 09/25/2003 | WO2003078641A1 Engineered baculoviruses and their use |
| 09/25/2003 | WO2003078640A2 Recombinant drug-sensitive vaccinia virus as smallpox vaccine |
| 09/25/2003 | WO2003078639A2 Transgenic plants expressing enzymes involved in fatty acid biosynthesis |
| 09/25/2003 | WO2003078638A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 09/25/2003 | WO2003078637A2 Optimizing glycan processing in plants |
| 09/25/2003 | WO2003078636A1 Transdifferentiation of cells and tissues |
| 09/25/2003 | WO2003078635A1 Gene participating in acetic acid tolerance, acetic acid bacterium bred using the gene, and process for producing vinegar with the use of the acetic acid bacterium |
| 09/25/2003 | WO2003078634A1 Novel carbonyl reductase, gene encoding it and process for producing optically active alcohols using the same |
| 09/25/2003 | WO2003078633A1 POLYPEPTIDES BINDING TO HUMAN SYNTAXIN 1a |
| 09/25/2003 | WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same |
| 09/25/2003 | WO2003078631A1 Novel genes |
| 09/25/2003 | WO2003078630A1 INHIBITION OF THE β3 SUBUNIT OF L-TYPE CA2+ CHANNELS |
| 09/25/2003 | WO2003078629A1 Constructs and methods for the regulation of gene expression |
| 09/25/2003 | WO2003078628A1 Methods for peptide and protein display in nucleic acid arrays |
| 09/25/2003 | WO2003078627A2 A building block capable of functional entity transfer to nucleophil |
| 09/25/2003 | WO2003078626A2 A building block capable of transferring a functional entity |
| 09/25/2003 | WO2003078625A2 An improved method for synthesising templated molecules |
| 09/25/2003 | WO2003078623A1 Functional molecule and process for producing the same |
| 09/25/2003 | WO2003078620A1 Mutated isopropylmalate isomerase |
| 09/25/2003 | WO2003078619A1 Hybrid and single chain meganucleases and use thereof |
| 09/25/2003 | WO2003078617A1 Production of usppase |
| 09/25/2003 | WO2003078616A1 Production of ugppase |
| 09/25/2003 | WO2003078615A1 Alcohol dehydrogenases with high solvent and temperature stability |
| 09/25/2003 | WO2003078614A2 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants |